The European Medicines Agency (EMA) has recommended sales to vets of medicines containing the “last resort” antibiotic colistin should be radically reduced.

Suggested new target levels could mean a 65% reduction in use of colistin across member states in an attempt to combat a growing threat of antimicrobial resistance following the identification of the plasmid-mediated colistin resistant (mcr-1) gene in China last year.

-65%Public Health England (PHE) scientists subsequently retested thousands of samples from the PHE Sequence Archive in this country, with 15 isolates (13 in humans and 2 in poultry meat) imported from the EU proving positive.

Reclassification bid

The EMA also wants colistin-containing medicines to be reclassified for use as a category two – second line treatment in animals.

The agency said, over the next three to four years, all member states should reduce the use of colistin in animals at least to a target level of 5mg colistin/population correction unit (PCU), where PCU is the estimated weight of livestock and slaughtered animals.

If successfully applied, this could result in an overall reduction of about 65% in the sales of colistin for veterinary use at an EU level.

‘Serious issue’

The VMD stated, even though UK sales were already below EMA targets, “nevertheless, this issue is taken seriously by the industry”.

It said: “Since the discovery of mcr-1 in November 2015, additional self-imposed restrictions have been brought in by the UK pig and poultry sectors, recognising the importance of keeping colistin as an antimicrobial of last resort.

“These initiatives are likely to decrease UK veterinary use of colistin even further over time.”

  • Read more about the EMA’s recommendation in the 15 August issue of Veterinary Times.
View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz

related content

Anonymous email survey will also ask how much the college's disciplinary role contributes to this culture, and where improvements to this can can be made.

4 mins

Batches of Inductofol and Vetofol have been recalled by Norbrook Laboratories after a problem during manufacturing was reported, says the directorate.

2 mins

The RSPCA has released CCTV footage that captures the moment a lurcher is tied to a fence and abandoned in the hope it will lead to more information.

4 mins

A UK equine hospital is understood to have become the first in the world to offer a same-day qPCR test broad enough to identify all species of ringworm in horses.

4 mins

Scientists studying the Komodo dragon believe they have discovered an important lead with the potential to develop drugs to combat antimicrobial resistance.

3 mins

Retired vet Frances Harcourt-Brown has spoken of her delight that a “very generous lady” has provided funds to help vets and VNs attend her rabbit-related CPD sessions.

5 mins